Redotex nf Anorexigenic and weight reducer. Extended release capsules. MEDIX.
Redotex NF is another medication authorized as part of the treatment of obesity. The difference with respect to Redotex is that the NF presentation (which means new formulation) does not have triiodothyronine and diazepam in its composition. Triodothyronine (T3) is a thyroid hormone that is indicated in patients with hypothyroidism. also Diazepam is a benzodiazepine that is used as a sedative or as an anxiolytic in patients with anxiety disorder
PHARMACEUTICAL FORM AND FORMULATION
Each CAPSULA extended release contains:
D-norpseudoephedrine ………………. 50.00 mg
Atropine sulfate ……………………. 0.36 mg
Aloin ………………………………………. 16.2 mg
Excipient, cbp 1 capsule.
Auxiliary in the treatment of exogenous obesity.
PHARMACOCINETICS AND PHARMACODYNAMICS
General: The pharmacokinetics of REDOTEX NF corresponds to that of its individual components, which is not modified by the interaction between them; However, the formulation in dialicels capsules maintains a sustained and prolonged release, which modifies in a certain way the maximum time (Tmax) maintaining a maximum concentration (Cmax) without peaks or valleys for a minimum of 12 hours in the initial administration. This helps to maintain optimal therapeutic levels during the total period of treatment.
The pharmacodynamics of REDOTEX NF corresponds to the interaction of its individual components resulting in a complementary therapeutic activity.
REDOTEX NF should not be given to patients with problems:
Neurological, serious psychiatric or personality disorders.
From hyperthyroidism, heart disease, high blood pressure, diabetes, liver and / or kidney failure, glaucoma.
Of anorexia, chronic insomnia, psychopathic personality, suicidal or homicidal tendencies. Of prostatic hypertrophy, glaucoma or any obstructive condition of the urinary tract or gastrointestinal tract.
During pregnancy or lactation.
Concomitantly with an MAOI or with other adrenergic agents or beta blockers.
It is recommended not to interrupt the treatment abruptly, only that the presence of some adverse effect requires it. Given its presentation in capsules, an alternate regimen of administration can be established every 3rd, 4th, 5th. day, until the interruption, which should be adapted to each patient. In addition, during the entire treatment period patients should be advised about the possibility of a decrease in reflexes while operating dangerous machinery or driving a car.
Patients should be advised of the use of local anesthetics for dental processes, without first consulting their doctor.
Patients should be advised not to open or chew the capsules; they should be swallowed to preserve the protective layer of the granules.
SECONDARY AND ADVERSE REACTIONS
These correspond to those described for the individual components of the formula.
The following effects may occur in individuals susceptible to sympathomimetics or anticholinergics. They are usually well tolerated for a few days if treatment is continued; otherwise, the drug should be discontinued: nervousness, insomnia, excitement, fatigue, mydriasis, photophobia, cycloplegia, palpitations, tachycardia, dry mouth and mucous membranes, flushing, nausea, vomiting, constipation or diarrhea, erythema, dysuria, urinary retention .
pills Redotex NF is another medication authorized as part of the treatment of obesity. The difference with respect to Redotex is that the NF presentation (which means new formulation) does not have triiodothyronine and diazepam in its composition.
capsules Redotex nf vs redotex
Both medications have proven effective in treating obesity in association with a reduced energy diet plan and exercise practice. The administration of Redotex for six months produces a weight loss of 13.55 kg and the waist circumference decreases on average 12.8 cm, while with Redotex NF a reduction of 10.31 kg and 8.2 cm is reported, respectively.2
According to the General Health Law, Redotex is a drug that belongs to fraction II, while Redotex NF is classified as faction III. Therefore, for your purchase it is essential to present a medical prescription in authorized establishments for the sale of controlled medicines (pharmacies). It should be noted that the prescription will be valid for thirty days from the date of preparation and in the case of Redotex it will be retained in the pharmacy that supplies it and will be registered in the control books, however Redotex NF may be filled up to three times with the prescription, which will be sealed and recorded in the control books on each visit, retained on the third occasion.3
Can I purchase Redotex or Redotex NF at sites other than pharmacies?